1. Agnati LF, Celani MF, Fuxe K (1983) Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites. Acta Physiol Scand 118: 79–81
2. Agnati LF, Fuxe K, Benfenati F, Battistini N, Zini I, Camurri M, Hokfelt T (1984) Postsynaptic effects of neuropeptide comodulators at central monoamine synapses. In: 5th International catecholamine symposium, june 12–16, Goteborg, Sweden. Scientific, medical and scholarly publications. Liss, New York
3. Agnati LF, Fuxe K, Benfenati F, Celani MF, Battistini F, Mutt V, Cavicchioli L, Galli G, Hokfelt T (1983) Differential modulation by CCK-8 and CCK-4 of 3H-spiperone binding sites linked to DA and 5-hydroxytryptamine receptors in the brain of the rat. Neurosci Lett 35: 179–198
4. Anden N-E, Dahlstrom A, Fuxe K, Larsson K, Olson L, Ungerstedt U (1966) Ascending monoamine neurons to the telencephalon and diencephalon. Acta Physiol Scand 67: 313–326
5. Andersson K, Fuxe K, Eneroth P, Agnati LF, Locatelli V (1980) Hypothalamic DA and noradrenaline nerve terminal systems and their reactivity of changes in pituitary-thyroid and pituitary-adrenal activity and to prolactin. In: Brambilla F, Racagni G, de Wied D (eds) Progress in psychoneuroendocrinology. Elsevier, Amsterdam, pp 395–406